semaglutide dose increase Dosage 101: How Much Is Just Right? Higher-dose Wegovy could increase patient

Individuals with gastroparesis may experience symptoms like nausea, vomiting, bloating, early satiety (feeling full quickly after eating small amounts), abdominal pain, and erratic blood glucose levels

Passionate about pharmacy advocacy

FDA has a more rapid approach for approval of chronic weight management drugs, permitting short phase 3 trials of 52 to 68 weeks without requiring pre-approval cardiovascular outcomes trials (CVOTs) whereas Europe insists on such trials

Regular monitoring and proper medical guidance ensure that the therapy remains safe and beneficial for the patient

Many tirzepatide patients do not require hospitalization to treat GI problems and instead just experience the more common side effects of the drug